Epidemiology and Outcomes

Selection of indicators reporting response rate in pharmaceutical trials for systemic lupus erythematosus: preference and relative sensitivity
Jingru Tian, Shuntong Kang, Dingyao Zhang, Yaqing Huang, Xu Yao, Ming Zhao, Qianjin Lu

Lupus Science & Medicine Oct 2023, 10 (2) e000942; DOI: 10.1136/lupus-2023-000942
Systemic Lupus Erythematosus Risk Probability Index: ready for routine use? Results from a Chinese cohort
Lin Zhang, Wentian Lu, Dong Yan, Zhichun Liu, Leixi Xue

Lupus Science & Medicine Sep 2023, 10 (2) e000988; DOI: 10.1136/lupus-2023-000988
Clinical outcome in patients with suspected inflammatory neuropsychiatric lupus treated with immunosuppression: an observational cohort study
Rory C Monahan, Liesbeth J J Beaart-van de Voorde, Rolf Fronczek, Jeroen de Bresser, Jeroen Eikenboom, Margreet Kloppenburg, Huub A M Middelkoop, Gisela M Terwindt, Nic J A van der Wee, Tom W J Huizinga, Gerda M Steup-Beekman

Lupus Science & Medicine Feb 2023, 10 (1) e000850; DOI: 10.1136/lupus-2022-000850
A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort
Manuel Francisco Ugarte-Gil, Rocio Violeta Gamboa-Cardenas, Cristina Reátegui-Sokolova, Victor Román Pimentel-Quiroz, Mariela Medina, Claudia Elera-Fitzcarrald, Zoila Rodriguez-Bellido, Cesar Augusto Pastor-Asurza, Risto Alfredo Perich-Campos, Graciela S Alarcón

Lupus Science & Medicine Feb 2023, 10 (1) e000874; DOI: 10.1136/lupus-2022-000874
Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): prespecified analysis of the phase III ustekinumab trial in patients with SLE
Anca D Askanase, Wei Tang, Qing Zuraw, Robert Gordon, Betsy Brotherton, Joan T Merrill

Lupus Science & Medicine Apr 2023, 10 (1) e000875; DOI: 10.1136/lupus-2022-000875
Infection-related hospitalisation in young adults with systemic lupus erythematosus: data from the National Inpatient Sample
Rashmi Dhital, Monica Guma, Dilli R Poudel, Christina Chambers, Kenneth Kalunian

Lupus Science & Medicine Apr 2023, 10 (1) e000851; DOI: 10.1136/lupus-2022-000851
Gender differences in SLE: report from a cohort of 417 Caucasian patients
Francesca Trentin, Viola Signorini, Maria Laura Manca, Giancarlo Cascarano, Luca Gualtieri, Davide Schilirò, Anastasiya Valevich, Chiara Cardelli, Linda Carli, Elena Elefante, Francesco Ferro, Chiara Stagnaro, Dina Zucchi, Chiara Tani, Marta Mosca

Lupus Science & Medicine Apr 2023, 10 (1) e000880; DOI: 10.1136/lupus-2022-000880
Frailty and emergency department utilisation in adults with systemic lupus erythematosus ≤65 years of age: an administrative claims data analysis of Medicaid beneficiaries
Sarah B Lieber, Musarrat Nahid, Iris Navarro-Millán, Mangala Rajan, Sebastian E Sattui, Lisa A Mandl

Lupus Science & Medicine Jul 2023, 10 (2) e000905; DOI: 10.1136/lupus-2023-000905
Clarifying misbeliefs about hydroxychloroquine (HCQ): developing the HCQ benefits versus harm decision aid (HCQ-SAFE) per low health literacy standards
Shivani Garg, Sancia Ferguson, Betty Chewning, Shelby Gomez, Jon Keevil, Christie Bartels

Lupus Science & Medicine Jul 2023, 10 (2) e000935; DOI: 10.1136/lupus-2023-000935
Centrally acting ACE inhibitor (cACEi) and angiotensin receptor blocker (cARB) use and cognitive dysfunction in patients with SLE
Chrisanna Dobrowolski, Michelle Barraclough, Jiandong Su, Milica Tanic, Kathleen Bingham, Lesley Ruttan, Dorcas Beaton, Joan Wither, Maria Carmela Tartaglia, Mary Sano, Mahta Kakvan, Dennisse Bonilla, Robin Green, Zahi Touma

Lupus Science & Medicine Jul 2023, 10 (2) e000923; DOI: 10.1136/lupus-2023-000923

Main menu

Epidemiology and Outcomes

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Epidemiology and Outcomes

Pages